RC
IDXX icon

Roundview Capital’s Idexx Laboratories IDXX Stock Holding History

Roundview Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-437
Closed -$246K – 362
2026
Q1 		$246K Buy
437
+2
+0.5% +$1.28K 0.02% 317
2025
Q4 		$294K Buy
+435
New +$296K 0.02% 292
2024
Q4 		– Sell
-3,265
Closed -$1.65M – 338
2024
Q3 		$1.65M Buy
3,265
+35
+1% +$17K 0.12% 160
2024
Q2 		$1.57M Buy
3,230
+35
+1% +$17.6K 0.12% 160
2024
Q1 		$1.73M Buy
3,195
+11
+0.3% +$6.01K 0.14% 146
2023
Q4 		$1.77M Buy
+3,184
New +$1.49M 0.16% 126
2022
Q1 		– Sell
-1,175
Closed -$774K – 303
2021
Q4 		$774K Buy
+1,175
New +$738K 0.08% 213

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Roundview Capital's IDXX Position: Q2 2026 in Review

Roundview Capital sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 437 shares — an estimated $246K sold.

Roundview Capital first reported a position in IDXX in Q4 2021 and held it in 7 quarters. The position peaked at $1.77M in Q4 2023. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Roundview Capital reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Roundview Capital sold 437 Idexx Laboratories shares in Q2 2026, an estimated $246K.
  • Roundview Capital first reported a position in Idexx Laboratories in Q4 2021 and held it in 7 quarters.
  • Roundview Capital's Idexx Laboratories position peaked at $1.77M in Q4 2023.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Roundview Capital's 13F filing for Q2 2026, filed 30 Jul 2026.